Field safety notice, national patient safety alert, device safety information, and medicines recall/notification
Weekly Update from GOV.UKPlease click on links below for further information
If there is no link available, details can be found on the MHRA (Medicines & Healthcare products Regulatory Agency) website
- Class 2 Medicines Recall: Pfizer Limited, Oxbryta 500mg Tablets (voxelotor), EL(24)A/44
- Class 3 Medicines Recall: Accord-UK Ltd, Trandolapril 0.5mg, 2mg, 4mg Capsules, EL(24)A/35
- Class 4 Medicines Defect Information: Sandoz Limited, Omeprazole products, EL(24)A/34
- Class 4 Medicines Defect Information: Dawa Limited, Paracetamol 500mg, 1000mg Film-Coated Tablets, EL (24)A/21
- Class 4 Medicines Defect Information: Orifarm UK Ltd, Concerta XL 18mg & 36 mg prolonged release tablets, EL (24)A/07
- Class 3 Medicines Recall: Torrent Pharma (UK) Limited, Ramipril 1.25mg tablets, EL(24)A/05
- Estriol (Imvaggis®) 0.03mg pessary is out of stock until mid-late May 2023
- • Clarithromycin 125mg/5ml oral suspension is out of stock until w/c 10th April 2023
• Clarithromycin 250mg/5ml oral suspension is in limited supply until w/c 10th April 2023
• Serious Shortage Protocols (SSP) for clarithromycin 125mg/5ml and 250mg/5ml oral suspension were issued on 06/04/2023 - Wockhardt is out of stock oxycodone 5mg/5ml oral solution until end of June 2023.
- Class 4 Medicines Defect Information: Albireo AB, Bylvay 1200 micrograms Hard Capsules, EL (23)A/01 – GOV.UK (www.gov.uk)
- Prenoxad 1mg/ml Solution for Injection in a pre-filled syringe, Macarthys Laboratories, (Aurum Pharmaceuticals Ltd), caution due to potential needles in sealed kits https://www.cas.mhra.gov.uk/ViewAndAcknowledgment/viewAlert.aspx?AlertID=103215
- MHRA – Class 4 Medicines Defect Information: Quadrant Pharmaceuticals Limited, Bezalip Mono 400mg Tablets, EL (22)A/38 Class 4 Medicines Defect Information: Quadrant Pharmaceuticals Limited, Bezalip Mono 400mg Tablets, EL (22)A/38 – GOV.UK (www.gov.uk)
- Recall of Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-hameln-pharma-ltd-amiodarone-hydrochloride-50-mg-slash-ml-concentrate-for-solution-for-injection-slash-infusion-el-22-a-slash-31
- Abbott recalls two infant formula powders because of the possible presence of Salmonella Feb 2022 Please see link to FSA recall: https://www.food.gov.uk/news-alerts/alert/fsa-prin-11-2022
- Tesco Max All-In-One Chesty Cough & Cold Lemon Sachets Oct 21
- Emerade Emerade 300mcg Patient Letter Emerade 500mcg Patient Letter
- Phyllocontin (Aminophylline) 225mg And 350mg Modified Release Tablets (Update On Sda/2021/003 Issued On 9 February 2021 Regarding Stock Exhaustion Date For Phyllocontin (Aminophylline) Continus 225mg). SDA-2021-003(U).pdf
- Choral Hydrate 143.3/Ranitidine April 21
- Fluoxetine 10mg April 21
- Diamorphone limited supply April 21
- Inhaled Budesonaide April 21
- Pneomovax 23 solution April 21
- Estradot® 75 microgram patches May 21 a Serious Shortage Protocol (SSP) has been issued for Estradot® 75 microgram patches. The SSP will enable community pharmacists in England and Wales to supply patients with Evorel® 75 microgram patches OR Estraderm MX® 75 microgram patches.
- Urgent Assessment/Treatment Following Ingestion Of ‘Super Strong’ Magnets
- MSN_2020_055U Desmopressin (DDAVP) 0.01% w_v (100mcg per 1ml) intranasal solution June 21
- Recall Of Co-Codamol 30/500 Effervescent Tablets, Batch 1k10121, Zentiva Pharma Uk Ltd NatPSA_2021_004_MHRA – co-codamol June 21
- Dexamethasone 0.1% (Maxidex®) 5ml eye drops June 21
- Champix ® (varenicline) 0.5mg and 1mg tablets – Supply Disruption June 21